Vivo Bio Tech share news, announcements and annual reports
NSE: VIVOBIOTBSE: 511509Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹13.87.
29 Oct: open ₹13.58, high ₹14.09, low ₹13.49
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹31 Cr3,302nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.60 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.72
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,84371.4% delivered
Vivo Bio Tech share news and announcements
594 announcements, routine notices left out, newest first. Page 2 of 12.
Sep 2025
24 Sep · Announcement under Regulation 30 (LODR)-Allotment
6 Sep · Meeting
Aug 2025
26 Aug · Board meeting
20 Aug · Business
12 Aug · Announcement under Regulation 30 (LODR)-Allotment
12 Aug · For Quarter Ended June 30, 2025
12 Aug · Results
6 Aug · Board meeting
Meeting on 12 Aug 2025: quarterly results4 Aug · Meeting
4 Aug · Meeting
4 Aug · Meeting
Jul 2025
14 Jul · Meeting
3 Jul · Announcement under Regulation 30 (LODR)-Allotment
3 Jul · Meeting
2 Jul · Board meeting
Meeting on 2 Jul 2025: increase in authorised capital2 Jul · Board meeting
Jun 2025
25 Jun · Announcement under Regulation 30 (LODR)-Allotment
18 Jun · Announcement under Regulation 30 (LODR)-Allotment
12 Jun · Meeting
11 Jun · Board meeting
Meeting on 11 Jun 202511 Jun · Management
11 Jun · Results
May 2025
28 May · Announcement under Regulation 30 (LODR)-Allotment
19 May · Board meeting
19 May · Results
13 May · Board meeting
Meeting on 19 May 2025: audited results
Apr 2025
17 Apr · Announcement under Regulation 30 (LODR)-Allotment
8 Apr · Announcement under Regulation 30 (LODR)-Allotment
Mar 2025
29 Mar · Announcement under Regulation 30 (LODR)-Allotment
5 Mar · Update Of Convertible Equity Warrants
3 Mar · Announcement under Regulation 30 (LODR)-Allotment
3 Mar · Announcement under Regulation 30 (LODR)-Allotment
Feb 2025
24 Feb · Announcement under Regulation 30 (LODR)-Allotment
21 Feb · Announcement under Regulation 30 (LODR)-Allotment